Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 7 records, 1 pages
Search For: GLP-1 Agonist
Global GLP-1 Agonist Supply, Demand and Key Producers, 2024-2030
03 Mar 2024
Pharma & Healthcare
The global GLP-1 Agonist market size is expected to reach $ 59500 million by 2030, rising at a market growth of 15.9% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Oral GLP-1 Agonist Supply, Demand and Key Producers, 2024-2030
28 Mar 2024
Pharma & Healthcare
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD4480.00
Add To Cart
Global Oral GLP-1 Agonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
28 Mar 2024
Pharma & Healthcare
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD3480.00
Add To Cart
Global GLP-1 Agonist Injection Supply, Demand and Key Producers, 2024-2030
28 Mar 2024
Pharma & Healthcare
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD4480.00
Add To Cart
Global GLP-1 Agonist Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
28 Mar 2024
Pharma & Healthcare
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD3480.00
Add To Cart
Global GLP-1 Agonist Supply, Demand and Key Producers, 2023-2029
02 Jun 2023
Pharma & Healthcare
The global GLP-1 Agonist market size is expected to reach $ 59500 million by 2029, rising at a market growth of 15.9% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global GLP-1 Agonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
02 Jun 2023
Pharma & Healthcare
According to our (Global Info Research) latest study, the global GLP-1 Agonist market size was valued at USD 21200 million in 2022 and is forecast to a readjusted size of USD 59500 million by 2029 with a CAGR of 15.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: GLP-1 Agonist
Total: 7 records, 1 pages
The global GLP-1 Agonist market size is expected to reach $ 59500 million by 2030, rising at a market growth of 15.9% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD4480.00
Add To Cart
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD3480.00
Add To Cart
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD4480.00
Add To Cart
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
USD3480.00
Add To Cart
The global GLP-1 Agonist market size is expected to reach $ 59500 million by 2029, rising at a market growth of 15.9% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global GLP-1 Agonist market size was valued at USD 21200 million in 2022 and is forecast to a readjusted size of USD 59500 million by 2029 with a CAGR of 15.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>